Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
NK cells in the tumor microenvironment and thioredoxin activity
Theresa L. Whiteside
Theresa L. Whiteside
View: Text | PDF
Commentary

NK cells in the tumor microenvironment and thioredoxin activity

  • Text
  • PDF
Abstract

NK cells are responsible for defense against viral infections and cancer. Although activated NK cells are armed to combat tumors, the tumor microenvironment (TME) contains ROS, which suppress NK cell antitumor activity. In this issue of the JCI, Yang, Neo, and colleagues explored NK cell resistance to oxidative stress in vitro and in human non–small-cell lung cancer (NSCLC). High surface thiol density and elevated expression of the ROS scavenger thioredoxin (Trx1) protected NK cells from ROS. Trx1 and thiol levels were higher in IL-15– than in IL-2–primed NK cells. Tumor-infiltrating Trx1+ NK cells were present in patients with NSCLC with elevated ROS levels in the tumor. Smokers scored higher for the ROS signature, which predicted poor prognosis, compared with nonsmokers. This study explains how activated NK cells survive in the ROS-rich TME and suggests that smokers with lung cancer may benefit from therapies using IL-15–primed NK cells.

Authors

Theresa L. Whiteside

×

Figure 1

The emergence of NK cells from obscurity to biological prominence.

Options: View larger image (or click on image) Download as PowerPoint
The emergence of NK cells from obscurity to biological prominence.
(A) W...
(A) When discovered in the 1980s, NK cells were recognized as CD45+CD56+CD16+ effector lymphocytes that did not express the T cell receptor or the B cell receptor. (B) Today, the NK cell surface is decorated by multiple receptors, only some of which are shown above. Sixteen activating proteins (NCRs, green), at least ten different KIRs, and various inhibitory receptors such as NKG2D or TRAIL (red), chemokine receptors (e.g., CXCR3 or CXCR4) and cytokine receptors (including IL-2R and IL-15R, blue), and adhesion molecules (e.g., DNAM-1, yellow) are expressed on NK cells. Further, NK cells produce a variety of cytokines and soluble factors that modulate functions of cells interacting with NK cells. NK cell–associated receptors and ligands are reported with regular frequency, as functionally diverse subsets of trNK cells are discovered and characterized. The study by Yang, Neo, and colleagues (11) reports that Trx1 content increases in activated NK cells and that the levels of thiols (purple) are upregulated on the cell surface, providing a protective screen against ROS.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts